An analysis of other primary cancers in individuals with non-Hodgkin's lymphoma (NHL) can help to elucidate this cancer aetiology. In all, 109 451 first primary NHL were included in a pooled analysis of 13 cancer registries. The observed numbers of second cancers were compared to the expected numbers derived from the age-, sex-, calendar period-and registry-specific incidence rates. We also calculated the standardised incidence ratios for NHL as a second primary after other cancers. There was a 47% (95% confidence interval 43 -51%) overall increase in the risk of a primary cancer after NHL. A strongly significant (Po0.001) increase was observed for cancers of the lip, tongue, oropharynx*, stomach, small intestine, colon*, liver, nasal cavity*, lung, soft tissues*, skin melanoma*, nonmelanoma skin*, bladder*, kidney*, thyroid*, Hodgkin's lymphoma*, lymphoid leukaemia* and myeloid leukaemia. NonHodgkin's lymphoma as a second primary was increased after cancers marked with an asterisk. Patterns of risk indicate a treatment effect for lung, bladder, stomach, Hodgkin's lymphoma and myeloid leukaemia. Common risk factors may be involved for cancers of the lung, bladder, nasal cavity and for soft tissues, such as pesticides. Bidirectional effects for several cancer sites of potential viral origin argue strongly for a role for immune suppression in NHL. 1992, 2002) indicates that this increase is occurring at an average annual rate of 4 -5% each year, implying a doubling of NHL incidence every 20 years. This upward trend has been observed in all geographical regions covered by cancer registration, and is not restricted to any particular age group or sex, or to predominantly rural or urban areas. The reason for the increase has attracted much speculation although there is no clear explanation for it.It has long been recognised that clusters of second primary cancers provide a unique clue to the understanding of cancer aetiology and mechanisms (Hanlon, 1931). If detection and other biases can be excluded, then the increased risk of an individual developing more than one primary cancer may be attributed to either (i) common risk factors between the cancers including environmental exposures and genetic factors, or (ii) effects of treatment, particularly chemo-and radiotherapy for the first primaries . It is often possible to distinguish between these two explanations. Cancers that share a common aetiology are likely to be increased after each other, whereas an increased incidence of treatment-related second primary cancers is often unidirectional. Furthermore, an increase in treatment-related cancers usually only becomes apparent years after the first primary cancer. To help elucidate the potential causes of NHL and the recent increasing incidence, we have therefore studied the occurrence of second primary cancers in over 109 000 patients with NHL from 13 cancer registries.